Expert-Agreed Practical Recommendations on the Use of Cladribine

Autor: Meca-Lallana V, García Domínguez JM, López Ruiz R, Martín-Martínez J, Arés Luque A, Hernández Pérez MA, Prieto González JM, Landete Pascual L, Sastre-Garriga J

Publikováno v: Neurology and Therapy
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Cladribine is a disease-modifying selective immune reconstitution oral therapy for adult patients with highly active relapsing multiple sclerosis (RMS). It was approved in the USA in 2019 and in Europe in 2017, thus there are still gaps in existing g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::e88c93ae404e25defadb553af0aecbc7
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13915

Escalas de valoración funcional en la esclerosis múltiple

Autor: Prieto-González Jm

Publikováno v: Revista de Neurología. 30:1246

Objective To review the characteristics which should be met by the scales for functional assessment of patients with multiple sclerosis in relation to the degree of invalidity, incapacity and handicap. Development The functional scales for neurologic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::06dfdc8ff1c1f214a401f951d33ea3cd
https://doi.org/10.33588/rn.3012.99501

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study.

Autor: Oreja-Guevara C; Department of Neurology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain; Department of Medicine, Medicine University, Complutense University of Madrid (UCM), Madrid, Spain. Electronic address: coreja@ucm.es., Meca-Lallana JE; CSUR Multiple Sclerosis and Clinical Neuroimmunology Unit, Neurology Department, Virgen de la Arrixaca Clinical University Hospital, IMIB-Arrixaca, Murcia, Spain., Díaz-Díaz J; Department of Neurology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain., Ara JR; Neurology Department, Miguel Servet University Hospital, Zaragoza, Spain., Hernández Pérez MÁ; Neurology Department, Nuestra Señora de la Candelaria University Hospital, Santa Cruz de Tenerife, Spain., Gracia Gil J; Neurology Department, Albacete University Hospital Complex, Albacete, Spain., Alonso Torres AM; CSUR Multiple Sclerosis, Neurology Department, Málaga Regional University Hospital, Málaga, Spain., Pilo de la Fuente B; Neurology Department, Getafe University Hospital, Madrid, Spain., Ramió-Torrentà L; Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital, IDIBGI, Girona, Spain., Eichau Madueño S; Neurology Department, Virgen Macarena University Hospital, Sevilla, Spain., Gascón-Giménez F; Neurology Department, Hospital Clínico de Valencia, Valencia, Spain., Casanova B; Neuroinmunology Unit, University and Polytechnic La Fe Hospital, València, Spain., Martínez-Yélamos S; Neurology Department, Bellvitge-IDIBELL University Hospital, L'Hospitalet De Llobregat, Barcelona, Spain., Aguado Valcárcel M; Neurology Department, Hospital Álvaro Cunqueiro, Vigo, Spain., Martínez Ginés ML; Neurology Department, Hospital Gregorio Marañón, Madrid, Spain., El Berdei Montero Y; Neurology Department, Salamanca University Hospital, Salamanca, Spain., López Real AM; Neurology Department, A Coruña University Hospital Complex, A Coruña, Spain., González-Quintanilla V; Neurology Department, Marqués de Valdecilla University Hospital, Cantabria, Spain., De Torres L; Neurology Department, Torrejón University Hospital, Madrid, Spain., Martínez-Rodríguez JE; Neurology Department, Hospital del Mar, Barcelona, Spain., Costa-Frossard L; Neurology Department, Ramón y Cajal University Hospital, Madrid, Spain., Garcés Redondo M; Neurology Department, Lozano Blesa Clinical University Hospital, Zaragoza, Spain., Labiano Fontcuberta A; Neurology Department, 12 de Octubre University Hospital, Madrid, Spain., Castellanos-Pinedo F; Neurology Department, Hospital Virgen del Puerto Plasencia, Cáceres, Spain., García Merino JA; Neurology Department, Puerta de Hierro University Hospital, Madrid, Spain., Muñoz Fernández C; Neurology Department, Torrecárdenas University Hospital, Almería, Spain., Castillo-Triviño T; Neurology Department, Donostia University Hospital, San Sebastián, Spain., Meca-Lallana V; Neurology Department, La Princesa University Hospital, Madrid, Spain., Peña Martínez J; Neurology Department, San Agustín University Hospital, Avilés, Asturias, Spain., Rodríguez-Antigüedad A; Neurology Department, Cruces-BioCruces Bizkaia University Hospital, Barakaldo-Bizkaia, Spain., Prieto González JM; Neurology Department, Santiago Clinical University Hospital, Instituto de Investigaciones Sanitarias de Santiago, Santiago de Compostela, Spain., Agüera Morales E; Neurology Department, Reina Sofia University Hospital, Córdoba, Spain., Pérez Molina I; Neurology Department, Hospital Virgen de la Salud, Toledo, Spain., Solar Sánchez DM; Neurology Department, Cabueñes University Hospital, Gijón, Spain., Herrera Varo N; Neurology Department, Burgos University Hospital, Burgos, Spain., Romero Sevilla R; Novartis Farmacéutica, S.A., Barcelona, Spain., Gómez Vicente L; Novartis Farmacéutica, S.A., Barcelona, Spain., Río J; Neurology Department, CEMCAT, Vall d'Hebrón University Hospital, Barcelona, Spain.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Oct; Vol. 90, pp. 105787. Date of Electronic Publication: 2024 Aug 02.